After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Allogene Therapeutics Inc. (ALLO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 2.00%, to $5.62. The Allogene Therapeutics Inc. has recorded 42,232 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-316 at the American Association of Cancer Research (AACR) Annual Meeting.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Stocks Info
ALLO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $5.51 and fluctuated between $5.64 as its day high and $5.36 as its day low. The current market capitalization of Allogene Therapeutics Inc. is $808.70M. A total of 1.38 million shares were traded on the day, compared to an average of 1.98M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ALLO has seen 1 BUY and 2 SELL insider trades, representing the acquisition of 251,908 and the disposition of 6,000 shares. Over the last 12 months, there were 10 BUYs and 15 SELLs from insiders. Insiders purchased 1,089,044 shares during that period but sold 22,118,574.
In the most recent transaction, Bhavnagri Veer sold 3,000 shares of ALLO for 6.85 per share on Feb 13. After the transaction, the General Counsel now owns 577,677 company shares. In a previous transaction on Jan 17, Bhavnagri Veer sold 3,000 shares at 7.04 per share. ALLO shares that General Counsel owns now total 580,677.
Among the insiders who sold shares, Bhavnagri Veer disposed of 5,602 shares on Dec 15 at a per-share price of $7.53. This resulted in the General Counsel holding 583,677 shares of ALLO after the transaction. In another insider transaction, WITTE OWEN N. sold 5,000 shares at $17.25 per share on Aug 12. Company shares held by the Director now total 218,271.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ALLO in the last 3 months, the mean price target is $17.40 with high estimates of $35.00 and low estimates of $6.00. In terms of 52-week highs and lows, ALLO has a high of $17.49 and a low of $5.41.
As of this writing, ALLO has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of -$0.53 per share and a lower estimate of -$0.84. The company reported an EPS of -$0.52 in the last quarter, which was 14.80% higher than expectations of -$0.61.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 18 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALLO is Underweight with a score of 4.38. A total of 13 analysts rated the stock as Buy while 1 rated it as Overweight while 3 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 0 thought it should be Sold.
